MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-15-2026
Aspira Women's Health EV - Enterprise Value 2011-2026 | AWH
Annual EV - Enterprise Value Aspira Women's Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.6 M | 6.28 M | 6.03 M | 118 K | 171 M | 86.2 M | 61.8 M | 42.6 M | 85.1 M | 61.7 M | 56.9 M | 45.5 M | 31.1 M | 15.8 M | 12.2 M | -3.5 M | -3.44 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 171 M | -3.5 M | 40.3 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
5.57 B | $ 88.78 | -3.99 % | $ 4.15 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 5.1 | -11.46 % | $ 6.78 M | USA |
 |
Fulgent Genetics
FLGT
|
583 M | $ 19.04 | -2.36 % | $ 586 M | USA |
 |
Castle Biosciences
CSTL
|
463 M | $ 21.38 | -1.02 % | $ 620 M | USA |
 |
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
15.2 B | $ 126.94 | -4.6 % | $ 15.9 B | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Illumina
ILMN
|
23.8 B | $ 162.14 | -3.52 % | $ 25.1 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 22.29 | -3.59 % | $ 1.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
16.5 B | $ 149.1 | -2.42 % | $ 11.7 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 103.22 | 0.39 % | $ 6.97 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 10.96 | -3.09 % | $ 1.4 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 183.58 | -1.2 % | $ 9.1 B | USA |
 |
Natera
NTRA
|
30.1 B | $ 217.28 | -2.17 % | $ 29.7 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 454.91 | -0.82 % | $ 13.1 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.46 | -10.74 % | $ 438 M | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 157.67 | -1.93 % | $ 23.9 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.65 | -0.85 % | $ 431 M | USA |
 |
National Research Corporation
NRC
|
432 M | $ 19.5 | -1.27 % | $ 436 M | USA |
 |
Personalis
PSNL
|
380 M | $ 11.17 | -7.69 % | $ 997 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.21 | 0.81 % | $ 24.9 B |  Niderland |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.78 | -3.28 % | $ 283 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.21 | 3.03 % | $ 5.08 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 264.33 | 1.23 % | $ 22 B | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 70.6 | -4.51 % | $ 4.22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 474.92 | -1.49 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
327 M | $ 0.72 | 4.53 % | $ 259 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 8.96 | -1.81 % | $ 1.94 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 200.0 | 1.96 % | $ 22.2 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |